Skip to main content

Table 6 The relationship between selected protein concentration and other parameters

From: Markers of increased atherosclerotic risk in patients with chronic kidney disease: a preliminary study

Table 6.

Hypertension

ALP ↑

CRP ↑

Fe ↓

↑ inorganic P

↑ Uric acid

↑ Urea

Fetuin A [ng/ml]

112.1±74.3

168.9±65.74

108.7±74.5

115.6±77.3

106.4±69.2

114.1±83.3

120.7±73.6

MMP-2 [ng/ml]

217.8±150.92

225.4±82.0

229.4±116.15

232.1±158.9

240.2±134.0

264.1±163.81

227.7±132.84

MMP-9 [ng/ml]

18.3±6.5

17.9±7.2

19.0±7.0

17.8±6.3

17.4±6.9

19.6±5.64

18.0±7.0

TIMP-1 [ng/ml]

21.5±2.7

21.1±2.2

21.4±2.2

21.8±2.4

21.3±2.1

20.9±2.54

21.5±2.4

MMP-2/TIMP-2

9.8±6.83

10.4±3.4

10.6±5.64

10.5±6.8

11.2±6.6

11.6±7.41

10.3±6.24

MMP-9/TIMP-1

0.84±0.35

0.86±0.41

0.88±0.39

0.83±0.33

0.82±0.37

0.91±0.316

0.83±0.41

Osteocalcin [ng/ml]

5.9±4.1

3.2±3.2

4.9±4.35

5.0±4.7

4.1±3.64

5.6±3.6

4.9±4.11

Osteopontin [ng/ml]

26.3±26.13

17.6±7.7

25.9±20.9

32.4±31.1

31.4±25.1

26.4±30.0

28.0±23.3

Osteoprotegerin [pmol/l]

7.3±5.81

8.2±4.3

7.2±4.9

7.9±5.84

9.5±6.41

7.4±5.7

7.3±5.6

MGP [ng/ml]

103.7±30.4

62.0±28.44

93.2±44.2

85.8±39.21

97.4±58.6

102.1±38.4

95.7±43.4

  1. 1 p<0.01; 2 p<0.0001; 3 p=0.065; 4 p<0.05; 5 p<0.07; 6 p<0.08